Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts

Cancer Research

Volumn 58, Issue 6, 1998, Pages 1305-1314

  LaRue, Karen E A ^a   Bradbury, E Morton ^a   Freyer, James P ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P18; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL KINETICS; ENZYME INHIBITION; ENZYME REGULATION; FIBROBLAST; GENE DISRUPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; ONCOGENE RAS; PRIORITY JOURNAL; SPHEROID CELL;

EID: 0032520932     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hunter, T., and Pines, J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
2. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
3. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
4. LeBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
5. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
6. Hall, M., Bates, S., and Peters, G. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene, 11: 1581-1588, 1995.
7. INK4-and p18-containing complexes in human cell lines. J. Biol. Chem., 271: 15942-15949, 1996.
8. Hirai, H., Roussel, M. F., Kato, J-Y., Ashmun, R. A., and Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15: 2672-2681, 1995.
9. INK4B/MTS2-related CDK6 inhibitor: correlates with wild-type pRb function. Genes Dev., 8: 2939-2952, 1994.
10. Sutherland, R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (Washington DC), 240: 177-184, 1988.
11. Freyer, J. P. Spheroids in radiobiology research. In: R. Bjerkvig (ed.), Spheroid Culture in Cancer Research, pp. 217-275. Boca Raton, FL: CRC Press, 1992.
12. Freyer, J. P., and Schor, P. L Automated selective dissociation of cells from different regions of multicellular spheroids. In Vitro Cell. Dev. Biol., 25: 9-19, 1988.
13. Freyer, J. P. Role of necrosis in regulating the growth saturation of multicellular spheroids. Cancer Res., 48: 2432-2439, 1988.
14. Land, H., Parada, L. F., and Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (Lond.), 304: 596-602, 1983.
15. Kunz-Schughart, L. A., Simm, A., and Mueller-Klieser, W. Oncogene-associated transformation of rodent fibroblasts is accompanied by large morphologic and metabolic alterations. Oncol. Rep., 2: 651-661, 1995.
16. Kunz-Schughart, L. A., Groebe, K., and Mueller-Klieser, W. Three-dimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation. Int. J. Cancer, 66: 578-586, 1996.
17. Kunz-Schughart, L. A., and Freyer, J. P. Adaptation of an automated selective dissociation procedure to multicellular spheroids of oncogene-transformed fibroblasts. In Vitro Cell. Dev. Biol., 33: 73-76, 1997.
18. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
19. Gibson, A. W., Cheng, T., and Johnston, R. N. Apoptosis induced by c-Myc overexpression is dependent on growth conditions. Exp. Cell Res., 218: 351-358, 1995.
20. Diehl, J. A., Zindy, F., and Sherr, C. J. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev., 11: 957-972, 1997.
21. Gu, Y., Rosenblatt, J., and Norgan, D. O. Cell cycle regulation of CDK2 activity by phosphorylalion of Thr-160 and Tyr-15. EMBO J., 11: 3995-4005, 1992.
22. Guadagno, T. M., Ohtsubo, M., Roberts, I. M., and Assoian, R. K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (Washington DC), 262: 1572-1575, 1993.
23. Girard, F., Strausfeld, U., Fernandez, A., and Lamb, N. J. C. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell, 67: 1169-1179, 1991.
24. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J., 11: 961-971, 1992.
25. Zhu, X., Ohtsubo, M., Bohmer, R. M., Roberts, J. M., and Assoian, R. K. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol., 133: 391-403, 1996.
26. Fang, F., Orend, G., Watanabe, N., Hunter, T., and Ruoslahti, E. Dependence of Cyclin E-CDK2 kinase activity on cell anchorage. Science (Washington DC), 271: 499-502, 1996.
27. Freyer, J. P., and Schor, P. L. Regrowth kinetics of cells from different regions of multicellular spheroids of four cell lines. J. Cell. Physiol., 138: 384-392, 1988.
28. Bernhard, E. J., Maity, A., Muschel, R. J., and McKenna, W. G. Effects of ionizing radiation on cell cycle progression: a review. Radiat. Environ. Biophys., 34: 79-83, 1995.
29. Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M., and Ross, R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of CDK2 inhibitors. Cell, 87: 1069-1078, 1996.
30. Wary, K. K., Mainiero, F., Isakoff, S. J., Marcantonio, E. E., and Giancotti, F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell, 87: 733-743, 1996.
31. Hansen, L. K., Mooney, D. J., Vacanti, J. P., and Ingber, D. E. Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol. Biol. Cell, 5: 967-975, 1994.
32. Kang, J-S., and Krauss, R. S. Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events. Mol. Cell. Biol., 16: 3370-3380, 1996.
33. Khosravi-Far, R., and Der, C. J. The Ras signal transduction pathway. Cancer Metastasis Rev., 13: 67-89, 1994.
34. Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrzanowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., and Der, C. J. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol., 16: 3923-3933, 1996.
35. Assoian, R. K., and Zhu, X. Cell anchorage and the cytoskeleton as partners in growth factor-dependent cell cycle progression. Curr. Opin. Cell Biol., 9: 93-98, 1997.
36. Stier, H., Karbach, U., Gerharz, C. D., Gabbert, H., and Nueller-Klieser, W. Oxygenation status of rhabdomyosarcoma spheroids with different stages of differentiation. Adv. Exp. Med. Biol., 345: 351-357, 1994.
37. Durand, R. E. Variable radiobiological responses of spheroids. Radiat. Res., 81: 85-99, 1980.
38. Casciari, J. J., Sotirchos, S. V., and Sutherland, R. M. Mathematical modeling of microenvironment and growth in EMT6/Ro multicellular tumor spheroids. Cell Prolif., 25: 1-22, 1992.
39. Freyer, J. P., Schor, P. L., and Saponara, A. G. Partial purification of a protein growth inhibitor from multicellular spheroids. Biochem. Biophys. Res. Commun., 152: 463-468, 1988.
40. Kip1 on resistance of tumor cells to anticancer agents. Nat. Med., 2: 1204-1210, 1996.